Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 33, Status: Authorised
Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Date of authorisation: 04/12/2016, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Ozurdex, dexamethasone, Date of authorisation: 26/07/2010, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised
ICMRA Summit 2025: EMA concludes its two mandates as chair
Minutes of the PRAC meeting 1-4 September 2025
Committee for Advanced Therapies (CAT) workshop on gene editing, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2025, 10:00 (CEST) to 16 September 2025, 17:00 (CEST)
Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised
Quality aspects of phage therapy medicinal products
Opinions and letters of support on the qualification of novel methodologies for medicine development